Downward Stream Of Drug Manufacturers In Focus –TEVA, WCRX, FRX, AMRN
Houston, TX –Jan 29, 2013 — (Net PR News) – AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Today’s Stocks in focus are: NYSE:TEVA, NASDAQ:WCRX, NYSE:FRX, NASDAQ:AMRN
During Previous Trading Session Drug Manufacturers Stocks Moving Downward – TEVA, WCRX, FRX, AMRN
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) declared that, on Thursday, February 7, 2013 at 7:00 a.m. EST, it will release its financial results of fourth quarter and full year 2012.
TEVA will discuss its overall business environment and results of fourth quarter and full year 2012 at 8:00 a.m. EST. On the same day, the company will host a conference call and also webcast live and after that the question and answer session will be started.
Get a Free Report and Detailed Analysis on TEVA CLICK HERE To Read
Teva Pharmaceutical Industries Ltd, during the previous trading session, showed a negative movement of -0.21%. Currently, the company has a market capitalization of $32.68 billion. The stock’s closing price was $37.65, while it started its day-trade at $37.67. Its 52-week price range was $36.63 – $46.65. Year to date performance of the stock remained positive with the rise of +0.83%. TEVA traded with volume of 3,905,400shares, while its average trading volume remained 5.70 million shares.
Warner Chilcott Plc (NASDAQ:WCRX) remained among the day gainers and traded with volume of 4,326,000 shares in the last trading session, as compared to average volume of 4.13 million shares.
The stock on Monday decreased -3.06% and finished the day at $13.30. WCRX was a decliner in the 5 days activity and slipped about -1.92%. The 52 week range of the stock remained $10.85 – $23.28. The one month performance of the stock was positive and it scored more than 13%.
How Should Investors React To WCRX Now? Find Out In This TREND ANALYSIS REPORT
Forest Laboratories, Inc. (NYSE:FRX) revealed that, from Health Canada, Forest Laboratories Canada Inc. has received a Notice of Compliance for BYSTOLIC® (nebivolol) tablets, a once daily beta blocker for the cure of hypertension.
Forest Laboratories, Inc. traded with a plunge of -0.79% and closed at $36.50 after gaining total volume of 1,161,300 shares. Its opening price was $36.97.
How Should Investors Trade FRX Now? Don’t Trade FRX until You Read This TREND ANALYSIS REPORT
If we look at the previous six month’s performance of the stock, it remained optimistic with the gain of 7.23%. In its last one month’s trade it gained 4.76%. Forest Laboratories’s earning per share is $0.42 while its beta value stands at 0.66 times.
Forest Laboratories has total market capitalization of $9.71 million with a total of 266.02million outstanding shares.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) opened at the price of $8.40, whereas its previous closing price was recorded at $8.28. Total volume of the stock was 4,260,200 shares during last trade, while its average volume is4.81 million shares.
Is AMRN A Solid Investment At These Levels? Find Out Exactly Where AMRN Is Headed With This TREND ANALYSIS REPORT
AMRN decreased -1.31% and traded within the range of $8.18 – $8.50 for the day, while the 52 week range of the stock remained in between $7.01 – $15.96. The Company’s total market capitalization stands at $1.24 billion, along with 149.77 million outstanding shares.
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.